October 2020 FDA Recall Childrens Ibuprofen by Aurobindo Pharma Usa Inc.
D-0065-2021 - Labeling Not Elsewhere Classified
This Class III drug recall was voluntarily initiated by Aurobindo Pharma Usa Inc. on October 22, 2020 for the product Childrens Ibuprofen. The FDA reported the reason for recall as labeling not elsewhere classified. The product was distributed in NJ and the recall is currently terminated.
Recall Number: D-0065-2021
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
10-22-2020
11-11-2020
7440 bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Aurobindo Pharma USA Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
NJ
04-04-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92
Batch or Lot Expiration Information
Lot# BO1020080AA3, EXP 7/2023